The next wave of diagnostic testing is for antibodies to #COVID29
Countries already on it or starting: Germany, Netherlands, UK, Singapore, South Korea, China
Country with no plan: US
economist.com/science-and-te…
wsj.com/articles/got-c… 1/x
Countries already on it or starting: Germany, Netherlands, UK, Singapore, South Korea, China
Country with no plan: US
economist.com/science-and-te…
wsj.com/articles/got-c… 1/x
There are many uncertainties w/ Ab testing:
—Do high levels of IgG protect from reinfection; how long do they persist, do they indicate an individual is incapable of spreading?
—The >20 tests vary w/r to methods, sensitivity, specificity, validation. Data are not transparent 2/x
—Do high levels of IgG protect from reinfection; how long do they persist, do they indicate an individual is incapable of spreading?
—The >20 tests vary w/r to methods, sensitivity, specificity, validation. Data are not transparent 2/x
The scalable tests (we need, massive, cheap quick) can be done in minutes via fingerstick.
Many resemble biopanda.co.uk test (according to @TheEconomist).
The one I did last week was far more comprehensive but may not well suited for mass use
3/x
Many resemble biopanda.co.uk test (according to @TheEconomist).
The one I did last week was far more comprehensive but may not well suited for mass use
3/x
The @CellexInc fingerstick #COVID19 antibody test, with 15-minute turnaround, cleared yesterday via @US_FDA, the 1st of many, and perspective about what it shows (and doesn't) nytimes.com/2020/04/02/hea… by @apoorva_nyc
Terrific to see that @COVID19Tracking is curating all the info on antibody/serology diagnostics 🙏 @hackingdata @airtable
airtable.com/shrGVEvpWp12Ry…
airtable.com/shrGVEvpWp12Ry…
